Amanda Del Rosario

Johnson & Johnson (United States) — United States

Medicine · Health Sciences

19h-index2.3kcitations51works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(8), Protein Degradation and Inhibitors(7), Pancreatic and Hepatic Oncology Research(5), RNA modifications and cancer(5), Peptidase Inhibition and Analysis(5)

Publications51 total

Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
Cell·2026· 1 citedOpen Access
Reductive C(sp<sup>2</sup>)–C(sp<sup>3</sup>) Coupling Protocol to Enable Linker Exploration of Cereblon E3-Ligase BRD4 Proteolysis-Targeting Chimeras
Journal of Medicinal Chemistry·2025· 6 cited
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
UNC Libraries·2025Open Access
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Nature·2025· 19 citedOpen Access
Measuring HSD17β13 protein turnover in mouse liver with D <sub>2</sub> O metabolic labeling and hybrid LC-MS
Bioanalysis·2025· 1 citedOpen Access
End-to-End Throughput Chemical Proteomics for Photoaffinity Labeling Target Engagement and Deconvolution
Journal of Proteome Research·2024
CRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretome
Microbial Cell Factories·2024· 3 citedOpen Access
CRISPR-Cas9 knockout screen informs efficient reduction of the <i>Komagataella phaffii</i> secretome
2024Open Access
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
2024· 2 citedOpen Access
Emergent mechanical control of vascular morphogenesis
Science Advances·2023· 32 citedOpen Access
Data from Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
2023Open Access
Supplementary Figures S1-S9 and List of Supplementary Tables from Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
2023Open Access
Supplementary Tables 1-10 from Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
2023Open Access
Data from Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
2023Open Access
Supplementary Tables 1-10 from Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
2023Open Access
Supplementary Figures S1-S9 and List of Supplementary Tables from Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
2023Open Access
Method Development Workflow for Quantifying Protein Biomarkers by Hybrid LC–MS/MS
Bioanalysis·2022· 9 cited
Alternative Splicing of FN (Fibronectin) Regulates the Composition of the Arterial Wall Under Low Flow
Arteriosclerosis Thrombosis and Vascular Biology·2020· 16 citedOpen Access
MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme
Nature Communications·2020· 46 citedOpen Access
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein Degradation
Cell chemical biology·2020· 52 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Forest M. White(16), Arjun Bhutkar(8), Tyler Jacks(8), Frank B. Gertler(8), Ruslan I. Sadreyev(7), Panyu Chen(7), Mandar D. Muzumdar(7), Kimberly Judith Dorans(7), Philipp Mertins(7), Jana Qiao(7), Anette Claudia Schafer(7), Steven A. Carr(7), Bryan D. Bryson(6), Jeannie T. Lee(6), Rebecca Robbins(6), Richard O. Hynes(5), Andrew S. DiChiara(5), Matthew D. Shoulders(5), Michael B. Yaffe(4), Kavitha Sarma(4)